Nihal AlMuraikhi

10PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2026
Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells.

Nihal Almuraikhi, Latifa Alkhamees, Sumaiya Tareen

|Mar 28, 2026
Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.

Rasha Elsayim, Heba W Alhamdi, Nihal Almuraikhi

|Feb 04, 2026
Evaluation of metformin's effect on 5-fluorouracil-induced cardiotoxicity through cellular protection.

Nahlah Fahad Alreshidi, Reham Abdullah Al-Dhelaan, Amjad Yousuf

|Jul 23, 2025
Dose-Dependent Effects of TGF-β Inhibition on Osteoblast Differentiation and Wound Healing.

Nihal Almuraikhi, Latifa Alkhamees, Sumaiya Tareen

|May 26, 2023
Inhibition of TGF-β type I receptor by SB505124 down-regulates osteoblast differentiation and mineralization of human mesenchymal stem cells.

Nihal Almuraikhi

|May 24, 2023
Transient downregulation of NR4A1 leads to impaired osteoblast differentiation through the TGF-ß pathway, and Elesclomol (STA-4783) rescues this phenotype.

Manikandan Muthurangan, Mona Elsafadi, Abdulaziz Siyal

Pageof 2

Frequent Collaborators

5 joint publications

Manikandan Muthurangan

1 joint publications

Norah A AlHowaish

1 joint publications

Amer Mahmood

1 joint publications

Almaha S Algazlan